MidCap US Equities

Components Performance/Risk
Period Return
74.3%
Return Rank
Strong
Risk Exposure
Average Risk

Newly published after original introduction in January 2023, this selection of MidCap US Equities has been very informative (and profitable) from the start 

  • Diversification across sectors, but deliberately underweight in technology 
  • Asset volatility moving in sync with the total market (beta ratio close to 1)
  • Strong momentum, defined as duration of a weekly price average trend outpacing a one-month trend

 

For in-depth comparison between the stocks, check the tabs providing additional data 

  • Analytics - check the list of 20 ratios - with quarterly updates of accounting data
  • Factor analysis - check asset correlation charts with 4 key factors (total market, small cap, value and profitability)

 

To narrow down your preferences, 

  •  Rank the funds over a selected time period from 1 year down to two weeks (top right menu) 
  • Evaluate the funds by performance and risk exposure rank
  • Check momentum ranking, the trend of the average price computed over a week, compared to the monthly price average

 

Assets in the selection, updated dynamically as the asset prices vary day-by-day, should always be evaluated on a case-by-case basis - to account for special events such as mergers or reverse splits

To test a potential investment in your virtual portfolio, the Impact feature of Pininvest portfolio management will evaluate the shift in performance, risk and diversification for your personnel portfolio

 

The midcap equities of the selection between $2 bn and $10 bn - in a range of 0.9 < asset betas < 1.05 - are an approximation of total market volatility, as defined by the Pininvest 1200 index 

Theme Components
Name
Ticker
Sector
Industry
Cur. Price
Mkt. Cap
Performance
Momentum
Risk Rank
Risk Contrib
 
Cathay General Bancorp CATY FinanceCommercial Banks (National & Regional)58.183.9 B41.7% Strong Up Low Risk
Enterprise Financial Services Corp EFSC FinanceCommercial Banks (National & Regional)61.042.2 B19.4% Weak Up Low Risk
CNO Financial Group, Inc. CNO FinanceAccident & Health Insurance47.124.4 B28.6% Strong Up Low Risk
Columbia Financial CLBK FinanceAsset Management20.252.1 B45.7% Weak Up Below Average
Calumet Specialty Products Partners CLMT EnergyOil & Gas Refining/Marketing37.413.2 B128.5% Weak Up Above Average
Catalyst Pharmaceuticals CPRX Health CareBiopharmaceuticals31.293.8 B39.2% Strong Up Average Risk
LivaNova LIVN Health CareMedical Devices73.724.0 B62.0% Strong Up Average Risk
Krystal Biotech KRYS Health CareGene Therapies307.799.0 B132.4% Weak Up Above Average
Liquidia Technologies LQDA Health CareClinical trial work62.545.5 B374.9% Strong Up High Risk
Organon & Co OGN Health CareDrug Manufacturers -Specialty Pharma13.403.5 B39.5% Strong Up High Risk
1 – 10 of 25